EXPERIMENTAL CHEMICAL PNEUMONIA
1Laboratories of The Rockefeller Institute for Medical Research.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Directly introducing chloramine-T or Dakin's solution into the lungs causes bronchopneumonia. These chemical-induced lung injuries differ from infectious pneumonia but suggest a natural defense mechanism against infection and intoxication.
Area of Science:
- Pulmonary Medicine
- Toxicology
- Pathology
Background:
- The nasopharyngeal mucosa tolerates certain chloramine-T concentrations, but its effect on pulmonary tissue via direct bronchial introduction was unexplored.
- Previous research by Kline and Meltzer indicated that various substances like aleuronat, starch, egg yolk, and lecithin could induce pulmonary inflammation.
Purpose of the Study:
- To investigate the effects of direct intrabronchial administration of chloramine-T solutions and Dakin's solution on pulmonary tissue.
- To compare the induced pulmonary lesions with those caused by other chemical substances and infectious agents.
Main Methods:
- Intrabronchial injection of chloramine-T solutions and Dakin's solution in large volumes.
- Observation and characterization of pulmonary lesions, including their progression and resolution.
- Comparison with historical data on lung inflammation induced by aleuronat, starch, egg yolk, and lecithin.
Main Results:
- Intrabronchial administration of chloramine-T and Dakin's solution induced extensive bronchopneumonia.
- These lesions progressed for 2 days, then regressed, typically resolving by day 7.
- Chemical-induced consolidations were sterile, unlike infectious pneumonia, and differed in fibrin content and type (bronchopneumonia vs. lobar pneumonia) depending on the substance.
Conclusions:
- Direct bronchial introduction of certain chemical solutions can cause significant pulmonary injury, specifically bronchopneumonia.
- Chemical-induced lung consolidations share similarities with infectious pneumonia but are sterile.
- The anatomical findings in chemically induced pneumonia suggest a role in the body's defense and repair mechanisms against infection and intoxication.
Related Concept Videos
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: